关注
Fabio Nascimbeni
Fabio Nascimbeni
Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy
在 unimore.it 的电子邮件经过验证
标题
引用次数
引用次数
年份
Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and …
S Ballestri, S Zona, G Targher, D Romagnoli, E Baldelli, F Nascimbeni, ...
Journal of gastroenterology and hepatology 31 (5), 936-944, 2016
7312016
Sex differences in nonalcoholic fatty liver disease: state of the art and identification of research gaps
A Lonardo, F Nascimbeni, S Ballestri, DL Fairweather, S Win, TA Than, ...
Hepatology 70 (4), 1457-1469, 2019
7262019
Hypertension, diabetes, atherosclerosis and NASH: cause or consequence?
A Lonardo, F Nascimbeni, A Mantovani, G Targher
Journal of hepatology 68 (2), 335-352, 2018
6632018
NAFLD as a sexual dimorphic disease: role of gender and reproductive status in the development and progression of nonalcoholic fatty liver disease and inherent cardiovascular risk
S Ballestri, F Nascimbeni, E Baldelli, A Marrazzo, D Romagnoli, ...
Advances in therapy 34, 1291-1326, 2017
5192017
From NAFLD in clinical practice to answers from guidelines
F Nascimbeni, R Pais, S Bellentani, CP Day, V Ratziu, P Loria, A Lonardo
Journal of hepatology 59 (4), 859-871, 2013
4922013
Performance and limitations of steatosis biomarkers in patients with nonalcoholic fatty liver disease
L Fedchuk, F Nascimbeni, R Pais, F Charlotte, C Housset, V Ratziu, ...
Alimentary pharmacology & therapeutics 40 (10), 1209-1222, 2014
4912014
AISF position paper on nonalcoholic fatty liver disease (NAFLD): Updates and future directions
A Lonardo, F Nascimbeni, G Targher, M Bernardi, F Bonino, E Bugianesi, ...
Digestive and Liver Disease 49 (5), 471-483, 2017
3092017
Nonalcoholic fatty liver disease: Evolving paradigms
A Lonardo, F Nascimbeni, M Maurantonio, A Marrazzo, L Rinaldi, ...
World journal of gastroenterology 23 (36), 6571, 2017
2432017
Chronic hepatitis C virus infection and atherosclerosis: clinical impact and mechanisms
LE Adinolfi, R Zampino, L Restivo, A Lonardo, B Guerrera, A Marrone, ...
World journal of gastroenterology: WJG 20 (13), 3410, 2014
2032014
Global multi-stakeholder endorsement of the MAFLD definition
N Méndez-Sánchez, E Bugianesi, RG Gish, F Lammert, H Tilg, ...
The lancet Gastroenterology & hepatology 7 (5), 388-390, 2022
1792022
The independent predictors of non‐alcoholic steatohepatitis and its individual histological features. Insulin resistance, serum uric acid, metabolic syndrome, alanine …
S Ballestri, F Nascimbeni, D Romagnoli, A Lonardo
Hepatology Research 46 (11), 1074-1087, 2016
174*2016
Cardiovascular risk, lipidemic phenotype and steatosis. A comparative analysis of cirrhotic and non-cirrhotic liver disease due to varying etiology
P Loria, G Marchesini, F Nascimbeni, S Ballestri, M Maurantonio, ...
Atherosclerosis 232 (1), 99-109, 2014
1462014
Statins, antidiabetic medications and liver histology in patients with diabetes with non-alcoholic fatty liver disease
F Nascimbeni, J Aron-Wisnewsky, R Pais, J Tordjman, C Poitou, ...
BMJ open gastroenterology 3 (1), e000075, 2016
1362016
Fatty liver is associated with an increased risk of diabetes and cardiovascular disease-Evidence from three different disease models: NAFLD, HCV and HIV
A Lonardo, S Ballestri, G Guaraldi, F Nascimbeni, D Romagnoli, S Zona, ...
World journal of gastroenterology 22 (44), 9674, 2016
1322016
Ultrasonographic fatty liver indicator detects mild steatosis and correlates with metabolic/histological parameters in various liver diseases
S Ballestri, F Nascimbeni, E Baldelli, A Marrazzo, D Romagnoli, ...
Metabolism 72, 57-65, 2017
1312017
Association between primary hypothyroidism and nonalcoholic fatty liver disease: a systematic review and meta-analysis
A Mantovani, F Nascimbeni, A Lonardo, G Zoppini, E Bonora, ...
Thyroid 28 (10), 1270-1284, 2018
1272018
Role of ultrasound in the diagnosis and treatment of nonalcoholic fatty liver disease and its complications
S Ballestri, D Romagnoli, F Nascimbeni, G Francica, A Lonardo
Expert review of gastroenterology & hepatology 9 (5), 603-627, 2015
1262015
Pathogenesis and significance of hepatitis C virus steatosis: an update on survival strategy of a successful pathogen
A Lonardo, LE Adinolfi, L Restivo, S Ballestri, D Romagnoli, E Baldelli, ...
World journal of gastroenterology: WJG 20 (23), 7089, 2014
1222014
COVID-19 treatment options: a difficult journey between failed attempts and experimental drugs
A Bartoli, F Gabrielli, T Alicandro, F Nascimbeni, P Andreone
Internal and emergency medicine 16, 281-308, 2021
882021
A round trip from nonalcoholic fatty liver disease to diabetes: molecular targets to the rescue?
A Lonardo, S Lugari, S Ballestri, F Nascimbeni, E Baldelli, M Maurantonio
Acta diabetologica 56 (4), 385-396, 2019
872019
系统目前无法执行此操作,请稍后再试。
文章 1–20